Class 4 caution in use-DROPODEX EYE DROPS 0.1%

Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information.

MHRA drug alert Date: 24/2/26

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-rayner-pharmaceuticals-limited-dropodex-0-dot-1-percent-w-slash-v-eye-drops-solution-el-26-a-slash-10?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=eb00b060-2e05-4c84-b34c-0a9b0873151f&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email: medinfo.Rayner@apcerls.com, or telephone +44-800-041-8153

For stock control enquiries please email markclayton@rayner.com, or telephone 01903 258777.

Class 2 recall-KidNaps (Melatonin) 1mg in 1ml Oral Solution

Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.  

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sterling-pharmaceuticals-ltd-specials-manufacturer-ms-32515-kidnaps-melatonin-1mg-in-1ml-oral-solution-el-26-a-slash-09

MHRA drug alert date:24/02/26

Further Information

For medical information enquiries on this product, email centralmedicalinformation@veritonpharma.com or telephone +44 (0)1932 690325. 

For stock control enquiries, email orders@veritonpharma.com or telephone +44 (0)1932 690325.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-MOVICOL Ease Citrus Powder for oral solution

Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients.

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el-26-a-slash-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3b17a3ae-dec1-45f7-a6cf-bc6e69fd59c2&utm_content=immediately

MHRA drug alert date:17/02/26

Further Information

For all medical information enquiries and information on this product, please email MedInfo@norgine.com, or  telephone +44 1895 826606.

For stock control enquiries please email UKIsupport@norgine.com, or telephone +44 (0) 1895 826 600.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Company led recall - Nutricia Multiple Products

COMPANY LED RECALL

We have received a Recall from Danone

on Various products

Reason: Danone is recalling specific batches of Aptamil / Cow & Gate infant milk due to the possible presence of cereulide (toxin).

Please can you ensure that your stores quarantine the product listed below.

Further Information

https://www.food.gov.uk/news-alerts/alert/fsa-prin-05-2026

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution.

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-26-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ecd84602-31de-4417-ac67-2e894ecffebb&utm_content=immediately

MHRA drug alert date:03/02/26

Further Information

For medical information enquiries please use the following options:

Email: medinfo@syrimed.co.uk, or telephone +44 (0) 330 1359 422.

For stock control enquiries please email syriwholesale@bnsthamelabs.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion

Accord Healthcare limited is recalling a single batch due to an out of specification test result.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-accord-healthcare-ltd-carmustine-100-mg-powder-and-solvent-for-concentrate-for-solution-for-infusion-1-vial-100mg-powder-1-vial-of-3-ml-solvent-el-26-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bf9bdbd3-2473-4486-b6dd-04d2961a9c3c&utm_content=immediately

MHRA drug alert date: 2/2/26

Further Information

For medical information enquires please contact Accord Medical Information Department on 01271 385257 or email medinfo@accord-healthcare.com.

For stock control enquiries please contact our Customer Services Team on 0800 373573.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Aspar Ibuprofen tabs 200mg

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.

Product recall date: 29/01/26

MHRA recall link:Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07 - GOV.UK

MHRA recall date: 04/02/26

Further Information

For all enquiries regarding this product, please call 020 8205 9846 extension 2209 or email adrian.zahra@aspar.co.uk.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine)

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

MHRA Drug alert date: 29/01/26

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a09ef640-89c2-4758-9ee1-2f562cdba868&utm_content=immediately#download-documents

Eaststone Limited will be contacting customers who have received affected stock directly

Further Information

For more information or stock and, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 1) or email specials@eaststone.co.uk 

For medical information queries, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

For all other enquires place contact Eaststone Limited +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Arixtra solution for injection, pre-filled syringes

Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.

MHRA drug alert Date: 28/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone Viatris UK Healthcare Limited Medical Information on +44 (0)1707 853 000 (select option 1) or email info.uk@viatris.com.

For stock control enquiries please contact telephone Customer Services on +44 (0)1707 853 000 (select option 2).

Class 4 caution in use-Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval and release process.

MHRA drug alert Date: 27/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

For stock control enquiries please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.